← Back to Search

A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Phase 2 & 3
Waitlist Available
Research Sponsored by Immune Response BioPharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 weeks

Summary

This trial is testing NeuroVax™, a treatment for people with a worsening form of multiple sclerosis called Secondary Progressive MS. The goal is to see if it can reduce new brain damage over time. The study will compare the effects of NeuroVax™ on patients.

Eligible Conditions
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Analyses of clinical relapses
Immunologic evaluations
Measures of neurologic disability EDSS score
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: NeuroVaxExperimental Treatment1 Intervention
NeuroVax
Group II: IFA PlaceboPlacebo Group1 Intervention
IFA Placebo

Find a Location

Who is running the clinical trial?

Immune Response BioPharma, Inc.Lead Sponsor
4 Previous Clinical Trials
688 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
162 Patients Enrolled for Multiple Sclerosis
croAMBIG
1 Previous Clinical Trials
150 Total Patients Enrolled
1 Trials studying Multiple Sclerosis
150 Patients Enrolled for Multiple Sclerosis
Richard M Bartholomew, Ph.DStudy DirectorImmune Response BioPharma, Inc.
2 Previous Clinical Trials
162 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
162 Patients Enrolled for Multiple Sclerosis
~35 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top